Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma

British Journal of Neurosurgery

Volumn 26, Issue 6, 2012, Pages 813-817

  Kast, R E ^a   Lefranc, F ^b   Karpel Massler, G ^c   Halatsch, M E ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenesis; Dapsone; Glioblastoma; Interleukin 8; Seizure

Indexed keywords

DAPSONE; INTERLEUKIN 8; VASCULOTROPIN;

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; CYTOKINE RELEASE; GLIOBLASTOMA; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEIZURE; SKIN DISEASE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DAPSONE; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; NEUTROPHILS; SEIZURES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84870270500     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2012.674577     Document Type: Review

References (66)

1. Lopez-Gomez M, Corona T, Diaz-Ruiz A, Rios C. Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial. Neurol Sci 2011 May 17 [Epub ahead of print].
2. Dixit S, Hingorani M, Achawal S, Scott I. The sequential use of carmustine wafers (Gliadel ®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. Br J Neurosurg 2011;25:459-69.
3. Hargrave D. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Br J Neurosurg 2009;23:351-63.
4. Nicholas MK, Lukas RV, Chmura S, Yamini B, Lesniak M, Pytel P. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin Oncol 2011;38:243-53.
5. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 2005;7:122-33. (Pubitemid 40590513)
6. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735-41.
7. van Eeden SF, Terashima T. Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow. Leuk Lymphoma 2000;37:259-71. (Pubitemid 30162537)
8. Xia M, Qin S, McNamara M, Mackay C, Hyman BT. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 1997;150:1267-74. (Pubitemid 27152645)
9. Prat A, Biernacki K, Pouly S, Nalbantoglu J, Couture R, Antel JP. Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol 2000;59:896-906.
10. Choi J, Nordli DR Jr, Alden TD, et al. Cellular injury and neuroinf ammation in children with chronic intractable epilepsy. J Neuroinf ammation 2009;6:38.
11. Chaichana KL, Halthore AN, Parker SL, et al. Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg 2011;114:604-12.
12. Jaeckle KA, Ballman K, Furth A, Buckner JC. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 2009;73:1207-13.
13. Usery JB, Michael LM 2nd, Sills AK, Finch CK. A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 2010; 99:251-60.
14. Hasselmann O, Blau N, Ramaekers VT, Quadros EV, Sequeira JM, Weissert M. Cerebral folate deficiency and CNS inflammatory markers in Alpers disease. Mol Genet Metab 2010;99:58-61.
15. Sogut O, Guloglu C, Orak M, et al. Trauma scores and neuron-specif c enolase, cytokine and C-reactive protein levels as predictors of mortality in patients with blunt head trauma. J Int Med Res 2010;38:1708-20.
16. Stein DM, Lindell A, Murdock KR, et al. Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury. J Trauma 2011;70:1096-103.
17. Kalita J, Srivastava R, Mishra MK, Basu A, Misra UK. Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett 2010;473:48-51.
18. Asano T, Ichiki K, Koizumi S, et al. IL-8 in cerebrospinal fluid from children with acute encephalopathy is higher than in that from children with febrile seizure. Scand J Immunol 2010;71:447-51.
19. Billiau AD, Witters P, Ceulemans B, Kasran A, Wouters C, Lagae L. Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia 2007;48:1739-49. (Pubitemid 47352869)
20. Trysberg E, Blennow K, Zachrisson O, Tarkowski A. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther 2004;6:R551-6.
21. Stoeck K, Bodemer M, Zerr I. Pro-and anti-inf ammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 2006;172:175-81. (Pubitemid 43277503)
22. Kast RE. Chronic mild encephalopathy caused by hepatitis C virus: The evidence for a common psychiatric illness. Psychiatry 2002. Online http://www.priory.com/psych/hcv.htm
23. Vivithanaporn P, Maingat F, Lin LT, et al. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodef ciency Virus-1 neurotoxicity. PLoS One 2010;5:e12856.
24. Xiong H, Boyle J, Winkelbauer M, et al. Inhibition of longterm potentiation by interleukin-8: implications for human immunodef ciency virus-1-associated dementia. J Neurosci Res 2003;71:600-7. (Pubitemid 36158344)
25. Franciosi S, Choi HB, Kim SU, McLarnon JG. IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inf ammatory cytokines and COX-2 in cultured human microglia. J Neuroimmunol 2005;159:66-74. (Pubitemid 40126178)
26. Piperi C, Samaras V, Levidou G, et al. Prognostic signif cance of IL-8-STAT-3 pathway in astrocytomas: Correlation with IL-6, VEGF and microvessel morphometry. Cytokine 2011 Jun 17 [Epub ahead of print].
27. Samaras V, Piperi C, Levidou G, et al. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Hum Immunol 2009;70:391-7.
28. Charalambous C, Chen TC, Hofman FM. Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus 2006;20:E22.
29. Garnier D, Milsom C, Magnus N, et al. Role of the tissue factor pathway in the biology of tumor initiating cells. Thromb Res 2010;125(suppl 2):S44-50.
30. Magnus N, Garnier D, Rak J. Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. Blood 2010;116:815-8.
31. Versteeg HH, Peppelenbosch MP, Spek CA. Tissue factor signal transduction in angiogenesis. Carcinogenesis 2003;24:1009-13. (Pubitemid 36827252)
32. Dutzmann S, Gessler F, Harter PN, et al. The pro-migratory and proinvasive role of the procoagulant tissue factor in malignant gliomas. Cell Adh Migr 2010;4:515-22.
33. Yang SY, Miah A, Pabari A, Winslet M. Growth factors and their receptors in cancer metastases. Front Biosci 2011;16:531-8.
34. de la Iglesia N, Konopka G, Lim KL, et al. Deregulation of a STAT3-interleukin-8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 2008;28:5870-8.
35. Gabellini C, Castellini L, Trisciuoglio D, Kracht M, Zupi G, Del Bufalo D. Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma. J Neurochem 2008;107:871-82.
36. Kim SM, Kim DS, Jeong CH, et al. 2011. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochem Biophys Res Commun 2010;407:741-6.
37. Venza M, Visalli M, Alafaci C, et al. Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-ß and CCAAT/enhancer-binding homologous protein. Neurosurgery 2011;69:713-21.
38. Xie TX, Xia Z, Zhang N, Gong W, Huang S. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep 2010;23:725-32.
39. Yao XH, Ping YF, Chen JH, et al. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neurooncol 2008;86:47-53.
40. Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-KB induced invasion by gliomas. J Neurooncol 2011;101:227-35.
41. Hong TM, Teng LJ, Shun CT, Peng MC, Tsai JC. Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol 2009;93:289-301.
42. Sun S, Wang Q, Giang A, et al. Knock down of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-KB. J Neurooncol 2011;101:1-14.
43. Kast RE, Scheuerle A, Wirtz CR, Karpel-Massler G, Halatsch M-E. The rationale of targeting neutrophils with dapsone during glioblastoma treatment. Anticancer Agents Med Chem 2011 Jun 27 [Epub ahead of print].
44. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000;72:391-8.
45. Stillie R, Farooq SM, Gordon JR, Stadnyk AW. The functional signif cance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 2009;86:529-43.
46. Weiss N, Deboux C, Chaverot N, et al. IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J Neuroimmunol 2010;223:131-4.
47. Aerbajinai W, Liu L, Chin K, Zhu J, Parent CA, Rodgers GP. Glia maturation factor-y mediates neutrophils chemotaxis. J Leukoc Biol 2011;90:529-38.
48. Schruefer R, Lutze N, Schymeinsky J, Walzog B. Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. Am J Physiol Heart Circ Physiol 2005;288:H1186-92.
49. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009;10:301-12.
50. Wathen PI. Hansen's disease. South Med J1996;89:647-52. (Pubitemid 26250092)
51. Wolf R, Matz H, Orion E, Tuzun B, Tuzun Y Dapsone. Dermatol Online J 2002;8:2.
52. Gatti G, Hossein J, Malena M, Cruciani M, Bassetti M. Penetration of dapsone into cerebrospinal fluid of patients with AIDS. J Antimicrob Chemother 1997;40:113-5. (Pubitemid 27341642)
53. Hughes WT. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin Infect Dis 1998;27:191-204. (Pubitemid 28334441)
54. Tiono AB, Dicko A, Ndububa DA, etal. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg2009;81:969-78.
55. Chang DJ, Lamothe M, Stevens RM, Sigal LH. Dapsone in rheumatoid arthritis. Semin Arthritis Rheum 1996;25:390-403. (Pubitemid 26197397)
56. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophils adherence function. J Invest Dermatol 1992;98:135-40.
57. Grabbe J, Haas N, Moller A, Henz BM. Erythema elevatum diutinum-evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol 2000;143:415-20. (Pubitemid 30650416)
58. Schmidt E, Reimer S, Kruse N, Brocker EB, Zillikens D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol 2001;124:157-62. (Pubitemid 32476946)
59. Madsen KK, White HS, Schousboe A. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol Ther 2010;125:394-401.
60. Schousboe A, Madsen KK, White HS. GABA transport inhibitors and seizure protection: the past and future. Future Med Chem 2011;3:183-7.
61. Santamaria A, Ordaz-Moreno J, Rubio-Osornio M, Solis-Hernandez F, Rios C. Neuroprotective effect of dapsone against quinolinate-and kainate-induced striatal neurotoxicities in rats. Pharmacol Toxicol 1997;81:271-5. (Pubitemid 27511671)
62. Danik M, Puma C, Quirion R, Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identif ed glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. J Neurosci Res 2003;74:286-95. (Pubitemid 37193715)
63. Bobustuc GC, Baker CH, Limaye A, et al. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol 2010;12:917-27.
64. Bruyere C, Mijatovic T, L onez C, et al. Temozolomide-induced modif cation of the CXC chemokine network in experimental gliomas. Int J Oncol 2011;38:1453-64.
65. Kim SM, Oh JH, Park SA, et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 2010;28:2217-28.
66. Pasi F, Facoetti A, Nano R. IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation. Anticancer Res 2010;30:2769-72.